News

#AAN2018 – LEMS Doesn’t Affect Long-term Survival of Patients Without Cancer, Study Finds

Lambert-Eaton myasthenic syndrome (LEMS) that’s not associated with cancer is associated with early onset of the disease, but it does not have an impact on the long-term survival of patients, according to researchers. These findings are from a large-scale study conducted by Duke Myasthenia Gravis Clinic researchers. The team…

Woman Develops LEMS Associated with Breast and Cervix Cancers, Case Study Reports

Lambert-Eaton myasthenic syndrome (LEMS) has been linked to cancer, with more than half of LEMS patients having cancer, most of them a small cell lung cancer (SCLC). Researchers have now reported a rare case of LEMS associated with two types of cancer in a patient: breast cancer and small cell…

Researchers Report Rare Case of LEMS with Mostly Eye Symptoms

University of Missouri researchers presented a rare case of Lambert–Eaton myasthenic syndrome (LEMS) that initially showed eye muscle weakness as a primary symptom in a 59-year-old woman, according to a report in the journal Cureus. Myasthenia gravis and LEMS are two autoimmune disorders that share a…

Catalyst Seeks FDA Approval of Firdapse for Treatment of LEMS

Catalyst Pharmaceuticals filed a New Drug Application (NDA) with the U.S. Food and Drug Administration for Firdapse (amifampridine) as a treatment for Lambert-Eaton myasthenic syndrome (LEMS). “We are pleased to reach this regulatory milestone and believe that our NDA submission contains all of the necessary information…